Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022)Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment. https://www.advarra.com/

Accel Research Sites makes clinical trials more accessible with Devana Solutions’ PROPEL platform

Chapel Hill (February 22, 2022) – Accel Research Sites is bringing clinical trials to even more patients, right where they live and work, thanks to an industry-leading clinical trial platform from Devana Solutions.

Accel is the latest clinical trial network to convert to Devana’s PROPEL Enterprise Platform, which will help the organization connect central teams to site-based staff and clinicians. The company previously used Devana’s IGNITE platform to automate workflow at the start of studies and to gain insight into performance metrics.

“PROPEL literally brings the site to the patient,” according to Barry Lake, Devana Solutions’ CEO and Co-Founder. “Like most leading research site networks, our Accel client-partner has used our IGNITE technology to standardize the trial startup workflows and analytics for their central operations team but, with PROPEL, Accel’s clin-ops professionals collaborate in a common cloud with their site-based colleagues, providing patients with access to trials in the communities where they live and work. We are thrilled that the team at Accel is leading this transformational shift.”

Accel will use PROPEL to connect the centralized management team in Florida with clinicians across 24 sites. With the shift from IGNITE, Accel will see increased efficiencies and precision around site selection, as well as faster site startup and exceptional trial execution.

“When the pandemic hit, we at Accel had to reimagine many of our normal processes so we could both help with the global health crisis and continue to keep our participants healthy and safe,” said Lora Parahovnik, CEO. “Working with Devana has helped us become more efficient. We’re looking forward to continuing to push forward in clinical trial operations by leaning on a cutting-edge platform like PROPEL.”

Devana Solutions is a market leader in clinical trial SaaS for study startup automation, metrics capture and analytics. Accel has been a partner since 2019, recently moving to the PROPEL platform as the company has grown.

For more information about Devana Solutions, visit https://devanasolutions.com/. For more information about Accel Research Sites, visit https://accelresearchsites.com/.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials.

About Accel Research Sites

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

Devana Solutions Joins Global Leader in Blood Cancer Fight

Devana Solutions is proud to announce their sponsorship of the Leukemia & Lymphoma Society's Students of the Year program and Grace and Jack Sherner’s Raise Hope Together team.Devana Solutions is proud to announce their sponsorship of Team Raise Hope Together, formed by Grace and Jack Sherner, as part of the Leukemia & Lymphoma Society Students of the Year program. Students of the Year is a philanthropic leadership development program for exemplary high school students that fosters professional skills such as entrepreneurship, marketing, and project management. The students involved in this campaign raise funds for The Leukemia & Lymphoma Society, the world’s largest nonprofit fighting blood cancer.

The Sherners, along with their friend Theo Weiman, formed Team Raise Hope Together in honor of their children’s grandfather, Larry Thayer, who was diagnosed with CLL (Chronic Lymphocytic Leukemia) in 2007.

In April of this past year, their children’s aunt, Betsy, found a tumor on her left breast. Days later, she received a breast cancer diagnosis. In the months since, she has undergone a double mastectomy and a complete hysterectomy.

Devana Solutions is joining to be a part of the generation that puts an end to cancer and provides a monumental impact in the fight.

Devana Solutions’ CEO and Co-founder Barry Lake comments on the effort, “We are proud to support Leukemia & Lymphoma Society and the Students of the Year program. We strive to offer solutions to those committed to the fight against cancer, helping those researchers on the frontline close the gap in eliminating cancer by cutting time and costs in the drug development process. One day, we will defeat cancer!”

The Leukemia & Lymphoma Society is on a mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma and improve the quality of life for patients and their families. Since 1949, the Leukemia & Lymphoma Society has invested more than $1.5 billion in research to advance therapies and save lives. Today, blood cancer patients live longer because of these advancements made possible by the Leukemia & Lymphoma Society.

The family remains committed to defeating their diagnoses. “I continue to work on my personal recovery, which requires piecing together a new body, mind, and spirit,” their Aunt Betty said.

Join Devana Solutions before March 12 with your donation to Team Raise Hope Together.

Partner Spotlight: Aventiv Research

Aventiv Research Partner Spotlight

Chapel Hill, NC (December 8, 2021) – Devana Solutions is happy to announce a new client-partnership with Aventiv Research, a leading independent, multi-therapeutic clinical research center with seven locations across the greater Columbus, Ohio and Phoenix, Arizona regions. As an alliance partner of hyperCORE International, a super network of highly experienced and awarded clinical research companies, Aventiv’s mission is to enrich the lives of their team members and patients by putting medical research to work. 

Founded in 2007 by Dr. Samir Arora, Aventiv Research has conducted over 475 clinical trials with more than 55 pharmaceutical sponsors and has assisted in the FDA approval of 23 medications available for use today. In addition to their research work and with over 30 years combined experience, Aventiv offers consulting services covering business development, site auditing and operations management, providing proper guidance on SOP implementation, quality assurance, staffing and infrastructure to ensure efficient and streamlined processes.

As a proven leader in the clinical trials industry, Aventiv has chosen to partner with Devana Solutions, the industry’s leading cloud-based technology provider, to help save time through workflow automation, from initial study lead through completion. “In addition to time saved, we now have robust, real-time clinical trial performance metrics to help improve trial execution and better align with our sponsors’ needs,” offered Dr. Samir Arora, President and Medical Director of Aventiv Research. “Devana’s data offerings support our goal to increase clinical trial efficiency.” Devana technology will reduce clinical trial cycle time, costs and ultimately, speed therapies to the market faster.

“I am pleased to have known Samir Arora for several years with Dr. Arora being a longtime leader in the clinical trials industry,” said Devana Solutions CEO, Barry Lake. “It’s humbling that so many of the industry leaders trust our Devana platform for metrics capture and analytics and connecting central teams to decentralized sites, and we’re very honored Dr. Arora and Aventiv Research have also placed their trust in Devana Solutions and our innovative platform.”

With an already excellent reputation for clean and quality data, it comes as no surprise that the Aventiv Research team has chosen to partner with Devana Solutions. “Our access to even more data sets will allow us to help advance our goal of expanding our expertise across vaccine, internal medicine, dermatology, and many other therapeutic areas,” added Rachel Flora, Business Development Manager for Aventiv. “As we gear up for 2022, the partnership with Devana has created a landscape for success for Aventiv. We will continue to work as a collaborative group by sharing insight and achievements to further set our network apart from our competitors.” The Devana team is excited to support this well-respected research organization to advance the clinical trials industry forward.

ABOUT AVENTIV RESEARCH:

Aventiv Research exists to make novel medicines accessible to its patients and deliver industry-best pharmaceutical data to its sponsors. Its mission is to enrich the lives of both its team members and patients by putting medical research to work. Currently operating in two states with seven independent research sites, Aventiv specializes in phase I-IV pharmaceutical, device, and diagnostic clinical trials in various therapeutic areas. Built on the core values of dedication, integrity, resourcefulness, and professionalism, the company embraces a visionary, entrepreneurial spirit that compels its ambassadors to blaze new trails with proprietary systems and processes.

Find out more at www.aventivresearch.com, Facebook, and Instagram.

 

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS.  PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites.  IQ allows for the sharing of performance data and documents in real-time between investigative sites and Sponsor or CRO stakeholders. To learn more visit www.devanasolutions.com.

 

 

 

Partner Spotlight | FOMAT Medical Research

Chapel Hill, NC (September 3, 2021) – Devana Solutions, LLC is pleased to announce their newest client-partnership with FOMAT Medical Research, an Integrated Research Organization and partner of the esteemed hyperCORE International, focused on drug, device, and vaccine development. With over ten years of multi-therapeutic clinical trial experience in Phases I-IV, FOMAT relies on a highly experienced clinical research team with the professional expertise needed to assist Sponsors and CROs in reaching their project goals quickly and effectively. To gain further support, FOMAT made the wise decision to implement Devana Solutions’ innovative IGNITE platform.

FOMAT’s mission is to diversify clinical trials throughout the United States & Latin America while innovating healthcare for underrepresented populations. Collaborations with health and urgent care centers, local churches, consulates, community events & centers- in addition to their internal EMR- provides access to over 100,000 patients. It ensures that Good Clinical Practice standards and ethics are upheld and understand that high-quality data is critical to the scientific community to offer improved treatments. Since implementing the Devana IGNITE platform, FOMAT is now armed with the data necessary to push its mission forward.

FOMAT ensures speedy yet compliant project execution for its Sponsor and CRO partners, with a goal of 48 hours to complete feasibility, site selection, and respond to contract, budget, and regulatory. By utilizing the intuitive Devana IGNITE platform, FOMAT can set internal performance goals and easily track its turnaround time metrics for all clinical trial stages. One such metric that FOMAT boasts is a 6-day turnaround time from award to First Patient In (FPI). Quite an accomplishment! These metrics are beneficial for FOMAT to gauge its internal performance and increase its predictability and reliability for its Sponsor and CRO partners.

“Very few of the leading independent research site organizations have not embraced the Devana Solutions platform for clinical trial process and performance transparency. Recently, that list got even shorter with FOMAT Medical Research becoming a Devana partner-client, joining the rest of the hyperCORE International leading site organizations to embrace the Devana Solutions’ innovative analytics and workflow automation platform,” said Devana Solutions, CEO, Barry Lake.

Devana Solutions is proud to partner with the very driven integrated research organization, FOMAT Medical Research, to help increase clinical trial efficiency and ultimately get treatments to patients faster.

ABOUT FOMAT MEDICAL RESEARCH:

FOMAT Medical Research, headquartered in Oxnard, California, is an Integrated Research Organization (IRO), a subset of a Site Management Organization (SMO), focused on innovating healthcare with our high-quality services. With over 10 years of experience in participating in Phase 1 through Phase 4 clinical trials in a wide variety of therapeutic areas, we rely on a highly experienced clinical research team with the professional expertise necessary to assist Sponsors and Contract Research Organizations (CRO) with reaching their project goals quickly and effectively.

Our sites are pre-qualified to ensure their performance will exceed expectations as quickly and effectively as possible. As soon as they enter our network, our sites abide by internationally recognized Good Clinical Practices (GCP) to ensure clinical trials are conducted ethically and effectively. At FOMAT Medical Research, we facilitate every stage of the clinical trial process and provide high-quality services and solutions for sponsors, CROs, and sites. To learn more, visit https://fomatmedical.com/.

ABOUT hyperCORE INTERNATIONAL:

FOMAT Medical Research is one of the founding partners of hyperCORE International’s alliance.

Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. To learn more, visit https://hypercoreinternational.com/.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Partner Spotlight | Icon Group

Devana Solutions, LLC is pleased to announce their newest client-partnership with the Icon Group, Australia’s.

About Devana Solutions: Devana Solutions is a SaaS provider driven by a core belief that performance data transparency through technology is critical to the selection of top-performing research sites to align with pharmaceutical sponsors and CROs to reduce drug development costs and cure disease

Partner Spotlight | SIGAL SMS

Chapel Hill, NC (June 23, 2021) – Devana Solutions, LLC is pleased to announce their newest client partnership with SIGAL Site Management and Support (SIGAL SMS). Founded in 2014, SIGAL SMS began a mission to support traditional private practices in their clinical research execution strategies throughout Germany. Today, the SIGAL SMS network connects over 25 sites across Germany, with an average experience of 55 multi-therapeutic studies and 21 years per site.

Realizing the challenges investigators and study teams face, SIGAL SMS offers extensive knowledge to help sites execute studies at the highest level. They offer complete project management support from study start-up to close-out, acting as a liaison between sites, sponsors and CROs. With their modernized approach, SIGAL SMS provides sponsors and CROs the confidence that studies are conducted in a quality and timely manner.

With a goal to standardize their modern approach in clinical trial conduct, SIGAL SMS needed a platform to help fill the technological gaps in their site and study oversight. Now, by leveraging the Devana IGNITE platform, SIGAL SMS has the ability to automate and centrally manage the processes at each site location to ensure that their studies are successful. With a high-level view into their organizational performance via IGNITE’s robust analytics dashboards, SIGAL SMS can assist sponsors and CROs with accurate site selection. From a single source, sponsors and CROs can obtain a group of professionally set up and qualified sites, with proof of their extensive experience in conducting studies and a high patient potential.

“The clinical trials industry has always been globally focused on advancing therapies to improve the human condition. The recent addition of SIGAL SMS, Germany’s leading research site management organization, onto the Devana Solutions’ platform is a testament to the global reach of the industry and our data analytics and workflow automation technology,” said Barry Lake, CEO & Co-Founder, Devana Solutions, LLC.

SIGAL SMS continues their mission to expand its investigative footprint throughout Germany and set a standard in clinical research at an international level. Devana Solutions is proud to support the SIGAL SMS team and their sites to efficiently carry out studies and advance medicine globally.

ABOUT SIGAL SMS:

SIGAL SMS (SIGAL Site Management & Support) is a Site Management Organization (SMO), which specializes in supporting the development, establishment and optimization of established physicians and outpatient practices nationwide in Germany, on their way to become a professional study site.
With their extensive experience in the field of clinical drug research, they know about the problems and difficulties faced by investigators and study teams as well as contractors – sponsors and CROs – every day in clinical trials. Based on this, they developed a concept and founded SIGAL SMS in 2014 to master these challenges as a reliable and competent partner. To learn more visit https://www.sigal-sms.de/en/.

ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.